Annual report pursuant to Section 13 and 15(d)

Investments (Tables)

v3.24.0.1
Investments (Tables)
 12 Months Ended
Dec. 31, 2023
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Equity Method Investments
Summarized combined financial information for these investments was as follows (amounts represent 100% of investee financial information, except Envestnet’s proportional share of losses):

December 31,
2023 2022
(in thousands)
Current assets $ 68,602  $ 42,059 
Other assets $ 66,016  $ 50,703 
Current liabilities $ 17,150  $ 17,647 
Other liabilities $ 1,857  $ 9,437 
Year Ended December 31,
2023 2022 2021
(in thousands)
Revenue $ 71,815  $ 79,062  $ 65,085 
Loss from operations $ (16,733) $ (8,896) $ (149)
Net loss $ (20,235) $ (7,124) $ (134)
Envestnet’s proportional share of gains (losses) (1)
$ (10,033) $ 643  $ (7,093)
__________________________________________________________
(1) The years ended December 31, 2023 and 2022 include a $0.5 million and $9.5 million dilution gain on equity method investee share issuance, respectively.